Serial scintigraphic assessment of iodine-123 metaiodobenzylguanidine lung uptake in a patient with high-altitude pulmonary edema

Chest. 1999 Oct;116(4):1129-31. doi: 10.1378/chest.116.4.1129.

Abstract

Iodine-123 metaiodobenzylguanidine ((123)I-MIBG) can be considered an indicator of pulmonary endothelial cell function. Serial (123)I-MIBG images of the chest were acquired in a patient with high altitude pulmonary edema (HAPE). The initial evaluation was performed 7 days after admission. The lung to upper mediastinum ratios (LMRs) of (123)I-MIBG uptake were 1.33 (for the right lung) and 1.12 (for the left lung). The second examination of (123)I-MIBG lung uptake, which was performed 2 months later, showed LMRs of 1.39 (right lung) and 1.33 (left lung). We speculated that the decreased lung uptake of (123)I-MIBG at the early recovery stage could reflect an impairment in pulmonary endothelial cell metabolic function in the development of HAPE.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine*
  • Altitude Sickness / diagnostic imaging*
  • Altitude Sickness / physiopathology
  • Endothelium, Vascular / diagnostic imaging
  • Endothelium, Vascular / physiopathology
  • Energy Metabolism / physiology
  • Humans
  • Iodine Radioisotopes*
  • Lung / diagnostic imaging
  • Male
  • Middle Aged
  • Pulmonary Edema / diagnostic imaging*
  • Pulmonary Edema / physiopathology
  • Radionuclide Imaging
  • Sensitivity and Specificity

Substances

  • Iodine Radioisotopes
  • 3-Iodobenzylguanidine